0.84
0.84 (0%)
As of Apr 17, 2025
Biovie Inc. [BIVI]
Source:
Company Overview
BioVie Inc. is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerativedisorders and advanced liver disease.
| Country | United States |
| Headquarters | carson city, nevada |
| Phone Number | 775-888-3162 |
| Industry | manufacturing |
| CEO | Cuong Do |
| Website | bioviepharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-7.3 |
| Net Income | $-7.1 |
| Net Cash | $0.6 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -28% |
| Profit as % of Stockholder Equity | -29.7% |
Management Effectiveness
| Return on Equity | -29.7% |
| Return on Assets | -27.7% |
| Turnover Ratio | |
| EBITA | $-7.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $25.7 |
| Total Liabilities | $1.8 |
| Operating Cash Flow | $-12.2 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $12.7 |
